Variant report
Variant | esv2563566 |
---|---|
Chromosome Location | chr1:185783040-185786062 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:185782674..185783372-chr1:186181707..186182270,2 | MCF-7 | breast: | |
2 | chr1:185773170..185775878-chr1:185781789..185784081,2 | MCF-7 | breast: | |
3 | chr1:185782255..185783272-chr1:186181370..186182154,4 | MCF-7 | breast: | |
4 | chr1:185782651..185783218-chr1:186124715..186125349,2 | MCF-7 | breast: | |
5 | chr1:185782207..185784224-chr1:186141376..186143598,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs368275873 | chr1:185783048-185783049 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs560677760 | chr1:185783053-185783054 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs6677289 | chr1:185783060-185783061 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs560525560 | chr1:185783095-185783096 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs11583047 | chr1:185783113-185783114 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs546344400 | chr1:185783152-185783153 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs191850161 | chr1:185783236-185783237 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs182922699 | chr1:185783309-185783310 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs187989698 | chr1:185783316-185783317 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs147897960 | chr1:185783356-185783357 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs570305923 | chr1:185783398-185783399 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs537726018 | chr1:185783409-185783410 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs80158128 | chr1:185783418-185783419 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs80352715 | chr1:185783419-185783420 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs79059795 | chr1:185783420-185783421 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs151088755 | chr1:185783430-185783431 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs556126899 | chr1:185783437-185783438 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs561499140 | chr1:185783504-185783505 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs72733232 | chr1:185783515-185783516 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs73072023 | chr1:185783561-185783562 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs543012315 | chr1:185783813-185783814 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs76615326 | chr1:185783831-185783832 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs1208456 | chr1:185783832-185783833 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs57781378 | chr1:185783841-185783842 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs578045907 | chr1:185783849-185783850 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs545210739 | chr1:185783858-185783859 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs544273692 | chr1:185783865-185783866 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs563125712 | chr1:185783886-185783887 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs141683914 | chr1:185783927-185783928 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs542485692 | chr1:185783983-185783984 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs562538682 | chr1:185783984-185783985 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs377067947 | chr1:185784022-185784023 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs143113886 | chr1:185784032-185784033 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs532951810 | chr1:185784044-185784045 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs151201391 | chr1:185784156-185784157 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs532225553 | chr1:185784158-185784159 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs192222065 | chr1:185784161-185784162 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs77856587 | chr1:185784221-185784222 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs368669481 | chr1:185784265-185784266 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs560466960 | chr1:185784270-185784271 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs570243398 | chr1:185784289-185784290 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs531152995 | chr1:185784291-185784292 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs185756262 | chr1:185784330-185784331 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs140356162 | chr1:185784342-185784343 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs372156443 | chr1:185784373-185784374 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs535052580 | chr1:185784464-185784465 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs114816803 | chr1:185784469-185784470 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs548925070 | chr1:185784499-185784500 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs567430125 | chr1:185784543-185784544 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs116562943 | chr1:185784574-185784575 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Bladder cancer | 19088036 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21509527 | CNVD |
Glioblastoma multiforme | 17369134 | CNVD |
Cancer | 17440070 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Nephroblastoma | 17189400 | CNVD |
Melanoma | 20688739 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21611746 | CNVD |
Myelofibrosis | 22110671 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 17393978 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Schizophrenia | 19197363 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:185780400-185785000 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
2 | chr1:185781000-185785200 | Weak transcription | NHDF-Ad | bronchial |
3 | chr1:185782800-185787800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
4 | chr1:185783000-185783200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
5 | chr1:185783000-185783200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
6 | chr1:185783000-185783600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
7 | chr1:185783600-185785400 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
8 | chr1:185785000-185787200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
9 | chr1:185785200-185786200 | Enhancers | NHDF-Ad | bronchial |
10 | chr1:185785200-185786400 | Enhancers | Foreskin Fibroblast Primary Cells skin02 | Skin |
11 | chr1:185785200-185786600 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
12 | chr1:185785400-185786000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |